Sitravatinib and Nivolumab for the Treatment of Metastatic or Advanced Clear Cell Renal Cell Cancer
Clinical trial NCT04904302 · TERMINATED
Trial details
- NCT number
- NCT04904302
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-03
- Primary completion
- 2026-03-11
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.